BR112013008602A2 - dispositivo imunocromatográfico, método para a determinação de um carreador gênico, método para o diagnóstico, dispositivo para ensaio imunológico, método para a detecção e determinação da presença de uma proteína e kit - Google Patents

dispositivo imunocromatográfico, método para a determinação de um carreador gênico, método para o diagnóstico, dispositivo para ensaio imunológico, método para a detecção e determinação da presença de uma proteína e kit

Info

Publication number
BR112013008602A2
BR112013008602A2 BR112013008602A BR112013008602A BR112013008602A2 BR 112013008602 A2 BR112013008602 A2 BR 112013008602A2 BR 112013008602 A BR112013008602 A BR 112013008602A BR 112013008602 A BR112013008602 A BR 112013008602A BR 112013008602 A2 BR112013008602 A2 BR 112013008602A2
Authority
BR
Brazil
Prior art keywords
determination
immunoassay
diagnosis
kit
protein
Prior art date
Application number
BR112013008602A
Other languages
English (en)
Other versions
BR112013008602B1 (pt
Inventor
Marco Grebe
Original Assignee
Grifols Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Therapeutics Inc filed Critical Grifols Therapeutics Inc
Publication of BR112013008602A2 publication Critical patent/BR112013008602A2/pt
Publication of BR112013008602B1 publication Critical patent/BR112013008602B1/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121Serpins
    • G01N2333/8125Alpha-1-antitrypsin
BR112013008602-5A 2010-09-24 2011-09-23 dispositivo imunocromatográfico, método para a determinação de um carreador gênico, método para o diagnóstico, dispositivo para ensaio imunológico, método para a detecção e determinação da presença de uma proteína e kit BR112013008602B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38621410P 2010-09-24 2010-09-24
US61/386,214 2010-09-24
US201161482867P 2011-05-05 2011-05-05
US61/482,867 2011-05-05
PCT/IB2011/002232 WO2012038820A2 (en) 2010-09-24 2011-09-23 Immunochromatography devices, methods and kits

Publications (2)

Publication Number Publication Date
BR112013008602A2 true BR112013008602A2 (pt) 2016-07-12
BR112013008602B1 BR112013008602B1 (pt) 2020-11-17

Family

ID=45874209

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013008602-5A BR112013008602B1 (pt) 2010-09-24 2011-09-23 dispositivo imunocromatográfico, método para a determinação de um carreador gênico, método para o diagnóstico, dispositivo para ensaio imunológico, método para a detecção e determinação da presença de uma proteína e kit

Country Status (22)

Country Link
US (2) US9121857B2 (pt)
EP (1) EP2619581B1 (pt)
JP (1) JP5852657B2 (pt)
KR (1) KR101753447B1 (pt)
CN (1) CN103140758B (pt)
AU (1) AU2011306651B2 (pt)
BR (1) BR112013008602B1 (pt)
CA (1) CA2811706C (pt)
CL (1) CL2013000813A1 (pt)
ES (1) ES2552649T3 (pt)
HK (1) HK1183514A1 (pt)
HU (1) HUE025584T2 (pt)
IL (1) IL225268A (pt)
MX (1) MX346499B (pt)
MY (1) MY172290A (pt)
NZ (1) NZ609824A (pt)
PL (1) PL2619581T3 (pt)
PT (1) PT2619581E (pt)
RU (1) RU2568875C2 (pt)
SG (1) SG189060A1 (pt)
WO (1) WO2012038820A2 (pt)
ZA (1) ZA201302099B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014159312A2 (en) * 2013-03-14 2014-10-02 University Of Florida Research Foundation, Incorporated A novel single chain antibody reduced mutant alpha-1 antitrypsin aggregation and toxicity
WO2014176556A1 (en) * 2013-04-26 2014-10-30 Express Diagnostics International, Inc. Portable testing system for detecting selected drugs or compounds in non-controlled environments
WO2017075050A1 (en) * 2015-10-26 2017-05-04 Wellbeing Technologies Corp. Lateral flow assay devices and methods
US20170212112A1 (en) * 2016-01-25 2017-07-27 General Electric Company Integration of sample separation with rapid diagnostic tests for improved sensitivity
US10983119B2 (en) 2016-01-25 2021-04-20 General Electric Company Device for rapid diagnostic tests to detect antigens with improved sensitivity
KR20180104648A (ko) * 2016-02-03 2018-09-21 노르딕 바이오사이언스 에이/에스 섬유증에 대한 조합된 바이오마커 측정법
JP7451403B2 (ja) * 2017-12-05 2024-03-18 ベクトン・ディキンソン・アンド・カンパニー 高濃度の分析物を検出するための側方流動アッセイ及び方法
CN108931653A (zh) * 2018-08-31 2018-12-04 广州华澳生物科技有限公司 一种α1- 抗胰蛋白酶免疫层析检测试剂卡及其制备方法
UY38696A (es) 2019-05-14 2020-11-30 Vertex Pharma Moduladores de alfa-1 antitripsina
EP3816626A1 (en) * 2019-10-30 2021-05-05 Feral GmbH Lateral flow test arrangement suitable for detection of an analyte in saliva
US20240012010A1 (en) 2020-11-12 2024-01-11 Vertex Pharmaceuticals Incorporated Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat
FR3119023A1 (fr) * 2021-01-21 2022-07-22 Ng Biotech Système pour l’analyse rapide d’un échantillon de sang capillaire provenant d’un sujet, destiné à la détection de la présence d’au moins un analyte dans ledit échantillon de sang capillaire
CN113075396A (zh) * 2021-03-25 2021-07-06 江苏硕世生物科技股份有限公司 一种检测辅助装置
CN113791209B (zh) * 2021-08-12 2024-01-26 重庆工商大学 一种无钩状效应的免疫层析试纸条及制备方法
CN114100871A (zh) * 2021-11-21 2022-03-01 黄红 血液分离器具

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904007D0 (sv) * 1989-11-28 1989-11-28 Ferring Ab Monoklona antikroppar och diagnostiseringsmetod
JPH11201969A (ja) 1998-01-14 1999-07-30 Wakamoto Pharmaceut Co Ltd 簡易遊離ヘモグロビン測定方法および測定用キット
GB9919226D0 (en) * 1999-08-13 1999-10-20 Medical Res Council Allele detection
EP1417491A4 (en) * 2001-07-18 2004-08-11 Siliang Zhou TEST STRIP FOR SIDE FLOW ASSAY OF A SAMPLE CONTAINING WHOLE CELLS
US20030092090A1 (en) * 2001-11-14 2003-05-15 Kiamars Hajizadeh Rapid prion-detection device, system, and test kit
US20060246513A1 (en) * 2005-05-02 2006-11-02 Bohannon Robert C Method and device to detect the presence of analytes in a sample
CN201203618Y (zh) * 2008-05-29 2009-03-04 重庆工学院 一种新城疫病毒免疫胶体金测试卡
CN102077091B (zh) * 2008-06-30 2016-08-17 积水医疗株式会社 用于结合测定的多孔性固相和使用所述多孔性固相的结合测定法
DE102009007616A1 (de) 2009-02-05 2010-08-12 Gaudlitz Gmbh Testvorrichtung für Flüssigkeiten des menschlichen oder tierischen Körpers

Also Published As

Publication number Publication date
ZA201302099B (en) 2017-08-30
CA2811706A1 (en) 2012-03-29
AU2011306651B2 (en) 2015-06-11
US20130183698A1 (en) 2013-07-18
US20150323526A1 (en) 2015-11-12
MX346499B (es) 2017-03-22
HUE025584T2 (en) 2016-04-28
PL2619581T3 (pl) 2016-02-29
PT2619581E (pt) 2015-12-02
AU2011306651A1 (en) 2013-04-04
NZ609824A (en) 2014-10-31
KR20130115262A (ko) 2013-10-21
RU2568875C2 (ru) 2015-11-20
BR112013008602B1 (pt) 2020-11-17
US9921229B2 (en) 2018-03-20
WO2012038820A3 (en) 2012-08-02
MX2013003161A (es) 2013-04-24
CN103140758A (zh) 2013-06-05
KR101753447B1 (ko) 2017-07-03
CL2013000813A1 (es) 2014-04-04
WO2012038820A2 (en) 2012-03-29
CN103140758B (zh) 2015-03-11
HK1183514A1 (en) 2013-12-27
JP2013539029A (ja) 2013-10-17
IL225268A (en) 2016-06-30
CA2811706C (en) 2017-03-28
RU2013118695A (ru) 2014-10-27
EP2619581A4 (en) 2014-04-09
EP2619581A2 (en) 2013-07-31
EP2619581B1 (en) 2015-09-30
MY172290A (en) 2019-11-20
IL225268A0 (en) 2013-06-27
ES2552649T3 (es) 2015-12-01
US9121857B2 (en) 2015-09-01
SG189060A1 (en) 2013-05-31
JP5852657B2 (ja) 2016-02-03

Similar Documents

Publication Publication Date Title
BR112013008602A2 (pt) dispositivo imunocromatográfico, método para a determinação de um carreador gênico, método para o diagnóstico, dispositivo para ensaio imunológico, método para a detecção e determinação da presença de uma proteína e kit
HK1201577A1 (en) Point-of care immunoassay for quantitative small analyte detection
BR112013013471A2 (pt) sistema de painel solar, kit de painel solar e método para determinar um estado operacional de um painel solar
BR112014002616A2 (pt) método para detectar cãncer pancreático e reagente ou kit para detectar câncer pancreático
BRPI0923199A2 (pt) métodos e composições para detecção de anticorpos com fixação de complemento.
BR112013022933A2 (pt) método de selagem de microesferas, método para detecção de molécula alvo, matriz, kit e dispositivo para detecção de molécula alvo
ES2685958T8 (es) Procedimiento para la detección temprana de trenes
DK2912183T3 (da) Pr13.5-promotor til robuste t-celle- og antistofresponser
GB201004292D0 (en) Assay for localised detection of analytes
DK2658542T3 (da) Topisk lokaliseret isoxazolinformulering
EP2554990A4 (en) MEASURING METHODS WITH IMMUNCHROMATOGRAPHY, TEST STRIPS FOR IMMUNCHROMATOGRAPHY AND MEASURING REAGENT KIT FOR IMMUNCHROMATOGRAPHY
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
EP2857837A4 (en) LYOPHILIZATION CONJUGATE STRUCTURE FOR IMMUNO-CHROMATOGRAPHIC CARE TESTING, IMMUNOLOGICAL ASSAY REQUIREMENTS USING THE SAME, AND ANALYSIS METHOD USING THE NECESSARY
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
BR112012033664A2 (pt) métodos para detecção da presença ou ausência de micro-organismos em uma amostra e dispositivo para detecção de micro-organismos
BR112012029866A2 (pt) método para a determinação da presença de uma proteína steap-1
EP3165923A4 (en) Marker, immunoassay method, immunoassay reagent, method for assaying analyte, kit for assaying analyte, and test strip for lateral flow chromatography
BR112013024004A2 (pt) método e aparelho para detectar a posição de uma transportadora.
BR112014011535A2 (pt) método para a determinação in vitro e imunológica de presença da presença e/ou da quantidade de um parceiro de ligação, método in vitro e utilização de um anticorpo
BRPI1015212A2 (pt) dispositivo e método para a detecção e para a análise quantitativa de analitos, especialmente micotoxinas
BR112014005505A2 (pt) substrato de polinucleotídeo isolado para uma enzima de ácido nucleico catalítica, método para detectar a presença de pelo menos um alvo, uso do substrato de polinucleotídeo isolado e kit
SG11201402709WA (en) Method and device for assaying an antigen present on erythrocytes or an antibody binding to an antigen present on erythrocytes
WO2012170206A3 (en) Color-producing diagnostic systems, reagents and methods
BR112015008473A2 (pt) aparelho e método para determinar a quantidade de uma proteína alvo e/ou outros tipos de biomarcadores ou analitos presentes em uma amostra

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/09/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2689 DE 19-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.